Expanded Medicare Coverage of Antiobesity Drugs May Cost Billions Each Year 0 08.10.2024 03:00 Jamanetwork.com Expanding Medicare coverage of a glucagon-like peptide-1 (GLP-1) receptor agonist to treat obesity could increase annual spending by several billion dollars, a study in Health Affairs found. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
